Eric Venker sold $7.3M of ROIV stock

Eric Venker, President & Immunovant CEO of Roivant Sciences Ltd. (ROIV), sold 200,000 shares of ROIV stock worth $7.3M, per an SEC Form 4 filed Nov 5, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Nov 3, 2026, 2 days before it was made public.

ROIV has moved +7.9% since the trade date, from $36.04 to $38.88 (Nov 6, 2026 close).